[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
January 1979

NetilmicinA New Aminoglycoside in the Treatment of Septic Burn Patients

Author Affiliations

From the Department of Surgery, Johns Hopkins University School of Medicine, and the Baltimore Regional Burn Center, Baltimore City Hospitals.

Arch Surg. 1979;114(1):28-30. doi:10.1001/archsurg.1979.01370250030005
Abstract

• Netilmicin sulfate, a new aminoglycoside antibiotic, was administered to ten patients with thermal burns who were suffering from septic complications, usually burn wound sepsis. There were seven survivors. Eighty-three percent of all clinical isolates recovered showed sensitivity to the drug. No renal or auditory side effects were noted in any of the patients.

(Arch Surg 114:28-30, 1979)

References
1.
Annual Report for 1975-1976 . US Army Institute of Surgical Research. US Army Research and Development Command, 1976.
2.
Pruitt BA, Foley FD:  The use of biopsies in burn patient care . Surgery 73:887-897, 1973.
3.
Zaske DE, Sawchuck RJ, Gerding DN, et al:  Increased dosage requirements of gentamicin in burn patients . J Trauma 16:824-828, 1976.Article
4.
Glew RH, Moellering RC, Burke JF:  Gentamicin dosage in children with extensive burns . J Trauma 16:819-823, 1976.Article
5.
Zaske DE, Sawchuck RJ, Strate RG: The necessity of increased doses of Amikacin in burn patient. Surgery, to be published.
×